2020 Q3 Form 10-Q Financial Statement

#000106299320005741 Filed on November 16, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q1 2019 Q3
Revenue $10.16M $12.09M $10.44M
YoY Change -2.68% 51.31% 20.83%
Cost Of Revenue $6.509M $7.250M $5.960M
YoY Change 9.22% 46.46% 19.44%
Gross Profit $3.651M $4.840M $4.490M
YoY Change -18.68% 59.21% 23.01%
Gross Profit Margin 35.94% 40.03% 43.01%
Selling, General & Admin $8.480M $8.410M $7.060M
YoY Change 20.11% 53.19% 62.3%
% of Gross Profit 232.25% 173.76% 157.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $184.4K $280.0K $239.8K
YoY Change -23.09% 12.0% 117.96%
% of Gross Profit 5.05% 5.79% 5.34%
Operating Expenses $8.660M $8.690M $7.300M
YoY Change 18.63% 51.66% 63.68%
Operating Profit -$4.231M -$3.850M -$2.811M
YoY Change 50.48% 43.12% 247.09%
Interest Expense -$130.0K -$130.0K -$110.0K
YoY Change 18.18% -7.14% -15.38%
% of Operating Profit
Other Income/Expense, Net -$130.9K -$113.5K
YoY Change 15.36%
Pretax Income -$4.360M -$3.980M -$2.920M
YoY Change 49.32% 40.14% 213.98%
Income Tax
% Of Pretax Income
Net Earnings -$4.362M -$3.980M -$2.925M
YoY Change 49.12% 40.14% 212.78%
Net Earnings / Revenue -42.93% -32.92% -28.02%
Basic Earnings Per Share
Diluted Earnings Per Share -$64.22K -$87.47K -$69.51K
COMMON SHARES
Basic Shares Outstanding 67.89M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q1 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.980M $4.560M $6.870M
YoY Change -42.07% -58.66% 55.78%
Cash & Equivalents $3.977M $4.562M $6.871M
Short-Term Investments
Other Short-Term Assets $2.620M $1.790M $2.020M
YoY Change 29.7% 371.05% 129.55%
Inventory $4.250M $2.920M $1.800M
Prepaid Expenses
Receivables $5.777M $4.917M $4.260M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.63M $14.18M $14.94M
YoY Change 11.31% -14.24% 48.95%
LONG-TERM ASSETS
Property, Plant & Equipment $1.120M $1.420M $1.690M
YoY Change -33.73% -27.18% 19.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.123M $1.423M $1.690M
YoY Change -33.53% -26.87% 19.01%
TOTAL ASSETS
Total Short-Term Assets $16.63M $14.18M $14.94M
Total Long-Term Assets $1.123M $1.423M $1.690M
Total Assets $17.75M $15.61M $16.63M
YoY Change 6.75% -15.56% 45.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.264M $5.407M $4.440M
YoY Change 18.57% 86.5% 77.6%
Accrued Expenses $1.512M $1.187M $1.030M
YoY Change 46.83% 8.31% 33.77%
Deferred Revenue
YoY Change
Short-Term Debt $4.800M $7.290M $4.010M
YoY Change 19.7% 132.91% 53.64%
Long-Term Debt Due $220.0K
YoY Change
Total Short-Term Liabilities $11.91M $13.98M $9.477M
YoY Change 25.71% 96.24% 59.82%
LONG-TERM LIABILITIES
Long-Term Debt $110.0K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $20.00K $10.00K
YoY Change 100.0%
Total Long-Term Liabilities $130.0K $0.00 $10.00K
YoY Change 1200.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.91M $13.98M $9.477M
Total Long-Term Liabilities $130.0K $0.00 $10.00K
Total Liabilities $12.05M $13.98M $9.490M
YoY Change 26.96% 96.24% 60.03%
SHAREHOLDERS EQUITY
Retained Earnings -$60.90M -$53.52M
YoY Change 38.32%
Common Stock $73.32K $45.59K
YoY Change 15.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.705M $1.622M $7.143M
YoY Change
Total Liabilities & Shareholders Equity $17.75M $15.61M $16.63M
YoY Change 6.75% -15.56% 45.24%

Cashflow Statement

Concept 2020 Q3 2020 Q1 2019 Q3
OPERATING ACTIVITIES
Net Income -$4.362M -$3.980M -$2.925M
YoY Change 49.12% 40.14% 212.78%
Depreciation, Depletion And Amortization $184.4K $280.0K $239.8K
YoY Change -23.09% 12.0% 117.96%
Cash From Operating Activities -$6.700M -$4.760M -$4.580M
YoY Change 46.29% 45.57% 284.87%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$250.0K -$170.0K
YoY Change -88.24% 31.58% 88.89%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$20.00K -$250.0K -$170.0K
YoY Change -88.24% 31.58% 88.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.090M 5.400M 1.620M
YoY Change 214.2% -52.63% -44.9%
NET CHANGE
Cash From Operating Activities -6.700M -4.760M -4.580M
Cash From Investing Activities -20.00K -250.0K -170.0K
Cash From Financing Activities 5.090M 5.400M 1.620M
Net Change In Cash -1.630M 390.0K -3.130M
YoY Change -47.92% -95.09% -288.55%
FREE CASH FLOW
Cash From Operating Activities -$6.700M -$4.760M -$4.580M
Capital Expenditures -$20.00K -$250.0K -$170.0K
Free Cash Flow -$6.680M -$4.510M -$4.410M
YoY Change 51.47% 46.43% 300.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2020Q3 wter Operating Lease Right Of Use Asset Noncurrent
OperatingLeaseRightOfUseAssetNoncurrent
23049 USD
CY2020Q3 us-gaap Notes Payable Current
NotesPayableCurrent
217561 USD
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2020Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
109599 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24408 USD
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-130933 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-113495 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
73563982 shares
dei Entity Small Business
EntitySmallBusiness
true
CY2020Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3976877 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
16629486 USD
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Type
DocumentType
10-Q
dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
4561682 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5777018 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4917081 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
4249581 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
2919860 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2504360 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1697199 USD
CY2020Q3 wter Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
121650 USD
CY2020Q1 wter Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
87393 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
14183215 USD
CY2020Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
1100373 USD
CY2020Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
1422581 USD
CY2020Q3 us-gaap Assets
Assets
17752908 USD
CY2020Q1 us-gaap Assets
Assets
15605796 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5264425 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5406541 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1512343 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1186516 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4797537 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7291217 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122380 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
99389 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11914246 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13983663 USD
CY2020Q3 us-gaap Liabilities
Liabilities
12048253 USD
CY2020Q1 us-gaap Liabilities
Liabilities
13983663 USD
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
66535665 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54094848 USD
CY2020Q1 wter Stock Payable
StockPayable
1000000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60904331 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5704655 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
8584951 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
7142599 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17752908 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15605796 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1622133 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4970767 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
11356913 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4361628 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2924957 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2900000 USD
CY2020Q2 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
258900 USD
CY2020Q3 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
4564323 USD
CY2019Q2 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
1180486 USD
CY2019Q3 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
1320000 USD
CY2020Q2 wter Stock Issued During Period Value Issued To Non Employees
StockIssuedDuringPeriodValueIssuedToNonEmployees
467300 USD
CY2020Q3 wter Stock Issued During Period Value Issued To Non Employees
StockIssuedDuringPeriodValueIssuedToNonEmployees
326599 USD
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000 USD
CY2020Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
661959 USD
CY2019Q3 us-gaap Depreciation
Depreciation
239757 USD
CY2020Q3 us-gaap Depreciation
Depreciation
184406 USD
CY2019Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1103740 USD
CY2019Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
162605 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
61480 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2020Q2 wter Stock Payable During Period Value
StockPayableDuringPeriodValue
1999998 USD
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
172521 CAD
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
16802 CAD
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4375000 CAD
us-gaap Use Of Estimates
UseOfEstimates
<div><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span><span><span style="text-decoration:underline">Use of Estimates</span></span></span></span></span></span></span></span></span></span></span></span></span></p><p style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span><span>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></span></span></span></span></span></span></span></span></span></span></span></p></div>
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45585592 shares
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
The principal amount of the Revolving Facility outstanding bears interest at a rate per annum equal to (i) a fluctuating interest rate per annum equal at all times to the rate of interest announced, from time to time, within Wells Fargo Bank at its principal office in San Francisco as its "prime rate," plus (ii) 3.25%, payable monthly in arrears. The interest rate as of September 30, 2020 was 7.0%.
wter Line Of Credit Facility Facility Fee
LineOfCreditFacilityFacilityFee
30000 USD
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73322472 shares
CY2020Q3 wter Temporary Over Advance
TemporaryOverAdvance
0 USD
CY2020Q3 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
8750000 shares
CY2020Q3 wter Lease Rate For Extension
LeaseRateForExtension
8231 USD
CY2020Q2 wter Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
0.90
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3272126 USD
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45585592 shares
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07 pure
CY2020Q3 wter Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
2.90
CY2020Q3 wter Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
2.90
CY2020Q3 wter Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
0.50
CY2020Q2 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
287666 shares
CY2020Q3 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
81400 shares
CY2020Q3 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
7999 shares
CY2020Q3 us-gaap Area Of Land
AreaOfLand
14530 sqft
CY2020Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7992 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
130989 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
144699 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
138266 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
146788 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6038 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-160150 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
146789 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M12D
wter Proceeds From Revolving Financing
ProceedsFromRevolvingFinancing
876919 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
79465 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
152827 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73322472 shares
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
3400 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
73321 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
45585 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53521700 USD
us-gaap Revenues
Revenues
24975370 USD
us-gaap Revenues
Revenues
20598022 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14696484 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11987627 USD
us-gaap Gross Profit
GrossProfit
10278886 USD
us-gaap Gross Profit
GrossProfit
8610395 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9490074 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9282342 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7437869 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6626642 USD
us-gaap Depreciation
Depreciation
412317 USD
us-gaap Depreciation
Depreciation
473697 USD
us-gaap Operating Expenses
OperatingExpenses
17340260 USD
us-gaap Operating Expenses
OperatingExpenses
16382681 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4230695 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2811462 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7061374 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7772286 USD
us-gaap Interest Expense
InterestExpense
321257 USD
us-gaap Interest Expense
InterestExpense
208859 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-321257 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-208859 USD
us-gaap Net Income Loss
NetIncomeLoss
-7382631 USD
us-gaap Net Income Loss
NetIncomeLoss
-7981145 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3021003 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5056188 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62646038 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41433694 shares
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2020Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
204594 USD
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
188081 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1187897 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4899998 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-262767 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-142116 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
327187 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8111516 USD
CY2020Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
116000 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
90109 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
210948 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90109 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-210948 USD
wter Proceeds From Revolving Financing
ProceedsFromRevolvingFinancing
-2493680 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1680453 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
859937 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67888935 shares
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2500486 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
807161 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7328002 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1266345 USD
CY2020Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
258899 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1329721 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1544643 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4823222 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
61480 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3377405 USD
us-gaap Interest Paid
InterestPaid
148862 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7616820 USD
us-gaap Interest Paid
InterestPaid
276813 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11032451 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3976877 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6870906 USD
wter Non Cash Investing And Financing Activities Operating Lease Right Of Use Asset
NonCashInvestingAndFinancingActivitiesOperatingLeaseRightOfUseAsset
130989 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
wter Issuance Of Common Shares To Settle Stock Payable
IssuanceOfCommonSharesToSettleStockPayable
1000000 USD
wter Non Cash Investing And Financing Activities Operating Lease Liability
NonCashInvestingAndFinancingActivitiesOperatingLeaseLiability
138266 USD
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
48158 shares
us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
-9907 USD
us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
13265 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1559527 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
325800 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
61480 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-584805 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2859809 USD
CY2020Q3 us-gaap Area Of Land
AreaOfLand
3352 sqft
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7891 USD
wter Lease Rate For Extension
LeaseRateForExtension
3938 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4161545 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4561682 USD
CY2020Q3 us-gaap Selling Expense
SellingExpense
1670523 USD
CY2019Q3 us-gaap Selling Expense
SellingExpense
1496708 USD
us-gaap Selling Expense
SellingExpense
3477554 USD
us-gaap Selling Expense
SellingExpense
2928163 USD
CY2020Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
0 shares
CY2019Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
3800000 shares
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
59461 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
94215 USD
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
21681 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
43753 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
73362 USD

Files In Submission

Name View Source Status
0001062993-20-005741-index-headers.html Edgar Link pending
0001062993-20-005741-index.html Edgar Link pending
0001062993-20-005741.txt Edgar Link pending
0001062993-20-005741-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wter-20200930.xml Edgar Link completed
wter-20200930.xsd Edgar Link pending
wter-20200930_cal.xml Edgar Link unprocessable
wter-20200930_def.xml Edgar Link unprocessable
wter-20200930_lab.xml Edgar Link unprocessable
wter-20200930_pre.xml Edgar Link unprocessable